Yatırımcı.AI

FSP vs HGH Fund Comparison

Price, period returns, size, investor count and risk score of FSP (Fonmap Portföy Serbest (Döviz) Fon) and HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) side by side.

SPK decided to liquidate HGH in bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed in the fund. Its returns in this comparison are based on the last price published on TEFAS (September 29, 2026). HGH fund page · SPK bulletin 2026/60

FSPHGH
StockFund

If You Had Invested TRY 10,000

Metric Comparison

FSP vs HGH Fund Comparison
MetricFSPHGHCategory median
Daily0.18%−0.08%−0.07%
1 week−0.31%−1.13%−0.29%
1 month−20.30%−3.45%0.00%
3 months−44.78%−9.23%4.33%
6 months−55.46%5.91%11.90%
YTD−57.66%8.00%14.97%
1 year−58.83%−12.05%21.27%
3 years—−31.08%111.30%
Returns are based on prices as of September 29, 2026; the fund with the higher return or the lower risk score counts as the leader.

Popular Comparisons

Popular Fund Comparisons

Related Pages

About the FSP vs HGH Comparison

The price, returns, size and risk of FSP (Fonmap Portföy Serbest (Döviz) Fon) and HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) are compared side by side as of September 29, 2026. Of the 10 metrics compared, FSP leads in 3 and HGH leads in 7. FSP is a Hedge Fund fund managed by Fonmap Portföy Yönetimi A.Ş.; HGH is a Hedge Fund fund managed by Hedef Portföy Yönetimi A.Ş..

Highlights: Daily: FSP leads (0.18% vs −0.08%). 1 week: FSP leads (−0.31% vs −1.13%). 1 month: HGH leads (−3.45% vs −20.30%). 3 months: HGH leads (−9.23% vs −44.78%). 6 months: HGH leads (5.91% vs −55.46%). YTD: HGH leads (8.00% vs −57.66%). 1 year: HGH leads (−12.05% vs −58.83%). Size (TRY): HGH leads (988.3K vs 79.8K). Investors: HGH leads (19 vs 15). Risk: FSP leads (6 vs 7).

Frequently Asked Questions

Year to date FSP returned −57.66% and HGH returned 8.00%; over the last year FSP returned −58.83% and HGH returned −12.05%. Over the last month FSP returned −20.30% and HGH returned −3.45%. Past performance does not indicate future returns.

As of September 29, 2026, FSP has a size of TRY 79.8K with 15 investors, while HGH has a size of TRY 988.3K with 19 investors. HGH leads in size and HGH leads in investor count.

The CMB risk score of FSP is 6 out of 7 and that of HGH is 7. The risk score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk. A lower score means less volatility, not a guarantee of higher returns.